Your browser doesn't support javascript.
loading
Do helminth infections underpin urban-rural differences in risk factors for allergy-related outcomes?
Nkurunungi, Gyaviira; Lubyayi, Lawrence; Versteeg, Serge A; Sanya, Richard E; Nassuuna, Jacent; Kabagenyi, Joyce; Kabuubi, Prossy N; Tumusiime, Josephine; Zziwa, Christopher; Kizindo, Robert; Niwagaba, Emmanuel; Nanyunja, Carol; Nampijja, Margaret; Mpairwe, Harriet; Yazdanbakhsh, Maria; van Ree, Ronald; Webb, Emily L; Elliott, Alison M.
Afiliación
  • Nkurunungi G; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Lubyayi L; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Versteeg SA; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Sanya RE; Department of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Nassuuna J; Departments of Experimental Immunology and of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Kabagenyi J; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Kabuubi PN; College of Health Sciences, Makerere University, Kampala, Uganda.
  • Tumusiime J; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Zziwa C; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Kizindo R; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Niwagaba E; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Nanyunja C; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Nampijja M; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Mpairwe H; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Yazdanbakhsh M; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • van Ree R; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
  • Webb EL; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Elliott AM; Immunomodulation and Vaccines Programme, (MRC/UVRI and LSHTM) Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda.
Clin Exp Allergy ; 49(5): 663-676, 2019 05.
Article en En | MEDLINE | ID: mdl-30633850
ABSTRACT

BACKGROUND:

It is proposed that helminth exposure protects against allergy-related disease, by mechanisms that include disconnecting risk factors (such as atopy) from effector responses.

OBJECTIVE:

We aimed to assess how helminth exposure influences rural-urban differences in risk factors for allergy-related outcomes in tropical low- and middle-income countries.

METHODS:

In cross-sectional surveys in Ugandan rural Schistosoma mansoni (Sm)-endemic islands, and in nearby mainland urban communities with lower helminth exposure, we assessed risk factors for atopy (allergen-specific skin prick test [SPT] reactivity and IgE [asIgE] sensitization) and clinical allergy-related outcomes (wheeze, urticaria, rhinitis and visible flexural dermatitis), and effect modification by Sm exposure.

RESULTS:

Dermatitis and SPT reactivity were more prevalent among urban participants, urticaria and asIgE sensitization among rural participants. Pairwise associations between clinical outcomes, and between atopy and clinical outcomes, were stronger in the urban survey. In the rural survey, SPT positivity was inversely associated with bathing in lakewater, Schistosoma-specific IgG4 and Sm infection. In the urban survey, SPT positivity was positively associated with age, non-Ugandan maternal tribe, being born in a city/town, BCG scar and light Sm infection. Setting (rural vs urban) was an effect modifier for risk factors including Sm- and Schistosoma-specific IgG4. In both surveys, the dominant risk factors for asIgE sensitization were Schistosoma-specific antibody levels and helminth infections. Handwashing and recent malaria treatment reduced odds of asIgE sensitization among rural but not urban participants. Risk factors for clinical outcomes also differed by setting. Despite suggestive trends, we did not find sufficient evidence to conclude that helminth (Sm) exposure explained rural-urban differences in risk factors. CONCLUSIONS AND CLINICAL RELEVANCE Risk factors for allergy-related outcomes differ between rural and urban communities in Uganda but helminth exposure is unlikely to be the sole mechanism of the observed effect modification between the two settings. Other environmental exposures may contribute significantly.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Población Rural / Población Urbana / Helmintiasis / Hipersensibilidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Uganda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Población Rural / Población Urbana / Helmintiasis / Hipersensibilidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Uganda